Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 27,381 $ 6,632
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization expense 20,247 20,893
Losses on disposal of assets 558 113
Earnings from unconsolidated affiliates (702) (1,419)
Deferred income taxes 2,341 (1,174)
Stock-based compensation expense 3,548 3,519
Amortization of deferred financing fees 954 718
Amortization of deferred contract costs 1,426 836
Increase (decrease) in cash resulting from changes in:    
Accounts receivable (36,615) (5,026)
Inventory, prepaid expenses and other assets (25,877) (13,093)
Accounts payable, accrued expenses and other liabilities 6,136 14,680
Net cash provided by (used in) operating activities (603) 26,679
Cash flows from investing activities:    
Capital expenditures (52,060) (64,562)
Proceeds from asset dispositions 37 5
Net cash used in investing activities (52,023) (64,557)
Cash flows from financing activities:    
Proceeds from borrowings 5,831 0
Debt issuance costs (238) (810)
Repayments of debt (4,795) (3,282)
Exercise of stock options 2 0
Purchase of treasury stock (2,495) (1,016)
Net cash used in financing activities (1,695) (5,108)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3,031) 2,242
Net decrease in cash, cash equivalents and restricted cash (57,352) (40,744)
Cash, cash equivalents and restricted cash at beginning of period 251,281 183,662
Cash, cash equivalents and restricted cash at end of period 193,929 142,918
Cash paid during the period for:    
Interest 17,670 16,910
Income taxes, net $ 12,929 $ 6,052